[ad_1] Major stock indexes ended mostly higher Wednesday, building on a long run of gains. The S&P 500 added 0.1%, notching an eighth-straight session in the green. The Nasdaq Composite…
Tag: Biogen
First Pill for Postpartum Depression Is Approved by FDA
[ad_1] The first pill to treat post-pregnancy depression will soon be available, after the Food and Drug Administration approved it. [ad_2] Source link
Biogen to cut 1000 more jobs by 2025
[ad_1] Biogen plans to lay off 1000 employees, over 11% of its global workforce, by 2025, as it reorganises to cut costs. The company already shed 900 staff worldwide in…
Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet
[ad_1] The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity. [ad_2] Source link
Alzheimer’s Blockbuster Is Coming, but Slowly
[ad_1] Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients. [ad_2] Source link
Medicare Plans to Cover Alzheimer’s Drugs
[ad_1] Biogen and Eisai’s Leqembi is up for full approval this summer. [ad_2] Source link
Eli Lilly Results Signal Arrival of Blockbuster New Drug Class
[ad_1] Share Listen (2 min) [ad_2] Source link
Climate | Biogen
[ad_1] In 2020, we announced targets for reducing our greenhouse gas emissions and our long-term vision by addressing fossil fuel emissions in our operations. Since then, we have prioritized areas…
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
[ad_1] A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration on Tuesday…
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
[ad_1] A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen isn’t worried about competing with Eli…